Spectrum Technology UK Ltd

We work with some of the world's leading clinicians to prove the effectiveness of ESWT as an alternative to invasive surgery. The Swiss DolorClast has been used successfully in many clinical trials:

---

‘ESWT proved significantly superior to placebo with a reduction of the visual analog scale score of 72.1% compared with 44.7% and an overall success rate of 61.0% compared with 42.2% in the placebo group at 12 weeks.'

Plantar fasciitis level 1 clinical trial - Gerdesmeyer et al 2008

---

---

‘After four months, eccentric loading alone was less effective when compared with a combination of eccentric loading and ESWT treatment.'

Achilles tendonopathy level 1 clinical trial - Rompe et al 2009

---

‘At 15 months from baseline, 40 of the 47 patients in the treatment group had been able to return to their preferred sport at their pre-injury level, compared to 22 of the 47 control patients. ESWT as applied was an effective treatment for Medial Tibial Stress Syndrome.'

Medial tibial stress syndrome level 3 clinical trial - Rompe et al.

---

‘For all outcome measures, the group that received the shockwave therapy showed significantly more favourable results than the group treated with eccentric loading physiotherapy. Eccentric loading physiotherapy showed inferior results to low-energy shockwave therapy treatment at four months follow-up.'

Chronic insertional achilles tendonopathy level 1 clinical trial - Rompe et al 2008